FDA Looms Large As Bayer Surrenders One A Day Selenium Prostate Claims
This article was originally published in The Tan Sheet
Executive Summary
Bayer seems to be heeding FDA's message that the administration will not tolerate playing fast and loose with health claims
You may also be interested in...
Selenium Claim Ruling Forces FDA's Hand, May Clear Path For More QHCs
A court decision obligating FDA to reconsider a slate of qualified health claims for selenium could compel the agency to allow more QHCs for dietary supplements
Selenium Claim Ruling Forces FDA's Hand, May Clear Path For More QHCs
A court decision obligating FDA to reconsider a slate of qualified health claims for selenium could compel the agency to allow more QHCs for dietary supplements
Selenium Claim Ruling Forces FDA's Hand, May Clear Path For More QHCs
A court decision obligating FDA to reconsider a slate of qualified health claims for selenium could compel the agency to allow more QHCs for dietary supplements